Unaccustomed physical activity with high intensity and eccentric contractions may cause muscle damage that may present itself as delayed onset muscle soreness (DOMS). 1 , 2 Indeed, DOMS is accepted as a type I muscle strain. 3 Stiffness, soreness, and tenderness of muscles are symptoms associated
Berkiye Kirmizigil, Jeffry Roy Chauchat, Omer Yalciner, Gozde Iyigun, Ender Angin and Gul Baltaci
Zeynep Hazar Kanik, Seyit Citaker, Canan Yilmaz Demirtas, Neslihan Celik Bukan, Bulent Celik and Gurkan Gunaydin
Delayed onset muscle soreness (DOMS) is a well-known phenomenon that occurs after unaccustomed or strenuous exercise, particularly if the exercise involves a lot of eccentric contractions. 1 Many theories have been proposed to explain the mechanism of DOMS, such as lactic acid accumulation, muscle
Will Abbott, Callum Brashill, Adam Brett and Tom Clifford
function and muscle soreness following a competitive soccer match in professional players. We hypothesized that TCJ supplementation would accelerate the recovery of muscle function and attenuate muscle soreness following a match. Methods Participants Twelve professional male soccer players from the reserve
Thilo Hotfiel, Marion Kellermann, Bernd Swoboda, Dane Wildner, Tobias Golditz, Casper Grim, Martin Raithel, Michael Uder and Rafael Heiss
Muscle injuries are one of the most common sports injuries, presenting an incidence up to 10% to 55% of all injuries. 1 – 3 Delayed onset muscle soreness (DOMS), an entity of ultrastructural muscle injury is classified as an overexertion-functional muscle disorder type Ib according to the “Munich
Kazunori Nosaka, P.▀ Sacco and K.▀ Mawatari
This study investigated the effect of a supplement containing 9 essential and 3 non-essential amino acids on muscle soreness and damage by comparing two endurance exercise bouts of the elbow fexors with amino acid or placebo supplementation in a double blind crossover design. The supplement was ingested 30 min before (10 h post-fasting) and immediately after exercise (Experiment 1), or 30 min before (2-3 h after breakfast), immediately post, and 8 more occasions over 4-day post-exercise (Experiment 2). Changes in muscle soreness and indicators of muscle damage for 4 days following exercise were compared between supplement conditions using two-way ANOVA. No significant differences between conditions were evident for Experiment 1; however, plasma creatine kinase, aldolase, myoglobin, and muscle soreness were significantly lower for the amino acid versus placebo condition in Experiment 2. These results suggest that amino acid supplementation attenuates DOMS and muscle damage when ingested in recovery days.
Lorette J. Pen, Craig Fisher, Gary A. Sforzo and Beth G. McManis
The effects of cognitive strategies on pain tolerance and performance in subjects with muscle soreness were investigated. Female (n = 18) and male (n =12) subjects were matched for strength and then randomly assigned to dissociation, association, or control groups. Muscle soreness was induced in the quadriceps and hamstrings muscle groups by repeated eccentric contractions against heavy resistance, which resulted in significant decrements in peak torque (PT) and total work (TW). ANOVAs revealed no significant group differences (p < .05) in muscle soreness, state anxiety, and estimated strength and endurance performance 48 hr following the soreness induction. Association strategy subjects increased their quadriceps strength performance following cognitive intervention, whereas strength performance in the dissociation and control groups was not affected. No significant treatment effects were observed for hamstrings strength or quadriceps and hamstrings endurance. Both dissociation and association groups perceived that using the strategies enhanced their performance. This illusory efficacy effect may have implications for performance enhancement, particularly in injury rehabilitation.
Jordan D. Philpott, Chris Donnelly, Ian H. Walshe, Elizabeth E. MacKinley, James Dick, Stuart D.R. Galloway, Kevin D. Tipton and Oliver C. Witard
leakage of myofiber proteins ( Clarkson & Hubal, 2002 ). These metabolic events are associated with delayed onset of muscle soreness (DOMS) and local muscular inflammation 24–48 hours after exercise ( Armstrong, 1984 ; Fridén & Lieber, 2001 ). With a view to minimizing muscle damage and/or accelerating
Joseph Hamill, Patty S. Freedson, Priscilla M. Clarkson and Barry Braun
This study involved an 8-day protocol to determine the effects of delayed-onset muscle soreness (DOMS) on the mechanics of the lower extremity and on oxygen consumption during level running. On Day 1 the subjects, 10 healthy female recreational runners, were administered a treadmill max V̇O2 test. They completed a 30-min downhill run on Day 3 to induce muscle soreness. On Days 2, 5, and 8 they completed a 15-min level run at a speed corresponding to 80% of V̇O2max. Subsequent to each run the subjects completed a muscle soreness questionnaire and a blood sample was taken for creatine kinase (CK) analysis. Data analysis revealed statistically significant between-day differences for perceived muscle soreness and CK activity. However, metabolic cost was not different between days. There were significant differences between days in maximum ankle support dorsiflexion and plantar flexion and maximum knee flexion during both support and swing. None of the global parameters describing the total stride produced significant differences between Days 2 and 5. Therefore DOMS appeared to have little effect on V̇O2 and a small effect on the kinematics of the lower extremity.
Dawn T. Gulick and Iris F. Kimura
Muscle soreness, a familiar phenomenon to most athletes, has been differentiated into “acute” and “delayed onset.” The etiology of acute muscle soreness has been attributed to ischemia and the accumulation of metabolic by-products. However, the etiology of delayed onset muscle soreness (DOMS) is not so clear. Six theories have been proposed: lactic acid, muscle spasm, torn tissue, connective tissue, enzyme efflux, and tissue fluid theories. The treatment of DOMS has also been investigated. Studies in which anti-inflammatory medications have been administered have yielded varying results based on the dosage and the time of administration. Submaximal concentric exercise may alleviate soreness but does not restore muscle function. Neither cryotherapy nor stretching abates the symptoms of DOMS. Transcutaneous electrical stimulation has been shown to decrease soreness and increase range of motion, but the effect on the recovery of muscle function is unknown. Therefore, the treatment of DOMS remains an enigma.
Paul G. Montgomery and Will G. Hopkins
Australian Football is an intense team sport played over ~120 min on a weekly basis. To determine the effects of game and training load on muscle soreness and the time frame of soreness dissipation, 64 elite Australian Football players (age 23.8 ± 1.8 y, height 183.9 ± 3.8 cm, weight 83.2 ± 5.0 kg; mean ± SD) recorded perceptions of muscle soreness, game intensity, and training intensity on scales of 1–10 on most mornings for up to 3 competition seasons. Playing and training times were also recorded in minutes. Data were analyzed with a mixed linear model, and magnitudes of effects on soreness were evaluated by standardization. All effects had acceptably low uncertainty. Game and training-session loads were 790 ± 182 and 229 ± 98 intensity-minutes (mean ± SD), respectively. General muscle soreness was 4.6 ± 1.1 units on d 1 postgame and fell to 1.9 ± 1.0 by d 6. There was a small increase in general muscle soreness (0.22 ± 0.07–0.50 ± 0.13 units) in the 3 d after high-load games relative to low-load games. Other soreness responses showed similar timelines and magnitudes of change. Training sessions made only small contributions to soreness over the 3 d after each session. Practitioners should be aware of these responses when planning weekly training and recovery programs, as it appears that game-related soreness dissipates after 3 d regardless of game load and increased training loads in the following week produce only small increases in soreness.